RecallDepth
Class II Terminated

Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
May 3, 2023
Posted
June 14, 2023
Recall Number
D-0869-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
12,336 bottles
Firm Location
Princeton, NJ, United States

Reason for Recall

CGMP Deviations

Distribution

Product was distributed to 19 distributors nationwide.

Lot / Code Info

Lot #: DND1515A, Exp 08/24

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls